Alkami Q2 Revenue Hits $129.8M, Adjusted EBITDA Surges 63%
ALKT sits 21% above its 52-week low of $13.98.
Summary
Alkami Technology posted Q2 2026 revenue of $129.8 million, a 15.9% increase, and adjusted EBITDA of $19.4 million, up 63% year-over-year. The company also initiated a $100 million stock repurchase program.
Key Events · Earnings and Guidance · ALKT
-
Q2 Revenue and Profitability Beat
Revenue reached $129.8 million, up 15.9% YoY, while adjusted EBITDA soared 63% to $19.4 million, driven by 37 new client wins and expanding user base.
-
$100M Buyback Authorized
Board authorized a $100 million stock repurchase program; $15 million executed in Q2 at an average price of $16.94, with an additional $10 million repurchased in July.
-
ARR Growth Accelerates
Annual Recurring Revenue (ARR) hit $511.7 million, up 20.7% YoY, reflecting strong subscription momentum and higher revenue per user.
-
Balance Sheet Strengthened
Revolving credit facility fully repaid; cash and marketable securities stand at $81 million, providing ample liquidity for operations and buybacks.
Analysis · ALKT · Technology
A strong second quarter saw revenue climb 15.9% to $129.8 million and adjusted EBITDA jump 63% to $19.4 million. Management underscored its confidence by launching a $100 million buyback, repurchasing $15 million in shares during the quarter and another $10 million in July. Although the net loss continues, the trajectory of improving profitability and the aggressive capital return speak to a brightening outlook.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALKT was trading at $16.89 on NASDAQ in the Technology sector, with a market capitalization of approximately $2B. The 52-week trading range was $13.98 to $28.53. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.